Theravance Biopharma Inc

-0.15 (-1.48%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)753.71M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$11.56 Million
Adjusted EPS-$0.13
See more estimates
10-Day MA$10.03
50-Day MA$9.50
200-Day MA$9.53
See more pivots

Theravance Biopharma Inc Stock, NASDAQ:TBPH

Ugland House, South Church Street, George Town, George Town KY1-1104
Cayman Islands
Phone: +1.650.808.6000
Number of Employees: 159


Theravance Biopharma, Inc. is a biopharmaceutical company, which engages in the discovery, research, development, and commercialization of respiratory medicines. It operates through the U.S. and Europe geographical segments. Its products include telavancin under the VIBATIV brand, revefenacin under the TD 4208 brand, and neprilysin. The company was founded in July 2013 and is headquartered in George Town, Cayman Islands.